Applied Molecular Transport Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 113
Employees
  • Stock Symbol
  • AMTI
Stock Symbol
  • Share Price
  • $10.94
  • (As of Friday Closing)

Applied Molecular Transport General Information

Description

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.

Contact Information

Formerly Known As
Applied Molecular Transport LLC
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 1 Tower Place
  • Suite 850
  • San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Applied Molecular Transport Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Applied Molecular Transport Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.94 $11.32 $10.52 - $78.22 $421M 38.5M 275K -$2.26

Applied Molecular Transport Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 805,401 926,708
Revenue 0 0 0 0
EBITDA (86,101) (64,951) (27,610) (29,239)
Net Income (89,165) (66,564) (28,043) (29,868)
Total Assets 207,056 140,183 38,533 23,244
Total Debt 12,209 636 100
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Applied Molecular Transport Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Applied Molecular Transport‘s full profile, request access.

Request a free trial

Applied Molecular Transport Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Applied Molecular Transport‘s full profile, request access.

Request a free trial

Applied Molecular Transport Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology plat
Biotechnology
San Francisco, CA
113 As of 2021
00000
00000000 00000

0000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaeca
000000000000000
Titusville, NJ
00000 As of 0000
00000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Applied Molecular Transport Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 000000 000 Venture Capital-Backed Titusville, NJ 00000 00000 00000
You’re viewing 1 of 1 competitors. Get the full list »

Applied Molecular Transport Patents

Applied Molecular Transport Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210171597-A1 Compositions, formulations and interleukin production and purification Pending 16-Aug-2019 00000000000
US-20210154304-A1 Compositions, formulations and interleukin production and purification Granted 16-Aug-2019 0000000000
US-11160869-B2 Compositions, formulations and interleukin production and purification Active 16-Aug-2019 000000000 000
EP-3844169-A1 Compositions, formulations, and interleukin production and purification Pending 16-Aug-2019 0000000000
US-20200140511-A1 Delivery constructs for transcytosis and related methods Abandoned 07-Nov-2018 C07K14/54
To view Applied Molecular Transport’s complete patent history, request access »

Applied Molecular Transport Executive Team (7)

Name Title Board Seat Contact Info
Tahir Mahmood Ph.D Board Member, Chief Executive Officer & Co-Founder
Shawn Cross Chief Financial Officer, Finance
Douglas Rich Chief Technical Officer
Douglas Rich Chief Technology Officer, Technology
Brandon Hants Chief Accounting Officer, Accounting & Senior Vice President
You’re viewing 5 of 7 executive team members. Get the full list »

Applied Molecular Transport Board Members (5)

Name Representing Role Since
Aaron VanDevender Ph.D Applied Molecular Transport Board Member 000 0000
David Lamond Self Board Member 000 0000
David Lamond JD Applied Molecular Transport Board Member 000 0000
Graham Cooper Self Board Member 000 0000
Helen Kim Applied Molecular Transport Chairman & Board Member 000 0000
To view Applied Molecular Transport’s complete board members history, request access »

Applied Molecular Transport Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Applied Molecular Transport Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Applied Molecular Transport‘s full profile, request access.

Request a free trial